Author:
Tayyari Farnoosh,Marchant David,Moraes Theo J,Duan Wenming,Mastrangelo Peter,Hegele Richard G
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference38 articles.
1. Collins, P.L. & Graham, B.S. Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 82, 2040–2055 (2008).
2. Wu, H., Pfarr, D.S., Losonsky, G.A. & Kiener, P.A. Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab. Curr. Top. Microbiol. Immunol. 317, 103–123 (2008).
3. Welliver, R.C. Pharmacotherapy of respiratory syncytial virus infection. Curr. Opin. Pharmacol. 10, 289–293 (2010).
4. Olszewska, W. & Openshaw, P. Emerging drugs for respiratory syncytial virus infection. Expert Opin. Emerg. Drugs 14, 207–217 (2009).
5. Magro, M., Andreu, D., Gomez-Puertas, P., Melero, J.A. & Palomo, C. Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein. J. Virol. 84, 7970–7982 (2010).
Cited by
309 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献